Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining -0.88% today. In the last week its performance is 2.08%, and 37.94% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 344.61, so today’s gain of -0.88% is a significant step towards its target price. The GAP today is therefore -0.28%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 67887.76, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.40%.
At the current price of 309.82, it has a dividend yield of *TBA, and its target price is 344.61. This is with a profit margin of 34.00%, and total debt/equity of 0.57. Biogen Inc. (NASDAQ:BIIB) has a P/E of 18.09, as well as a forward P/E of 14.87.
With a current EPS of 17.13, and a forecasted EPS growth for next year at 3.67%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 8.57%.
Performance for the year is 8.79%. Since its IPO date on 9/17/1991, the total performance to date is 1.13%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 922100, while its average volume is 1792.46. Whilst the total gain today was -0.88%, it did have a day high of -7.14%.
Volatility for this week has been at 1.71%, and 1.96% for the month. The 52-week low for Biogen Inc., BIIB has been 38.92%, while the 52-week-high has reached -7.14%.
Looking at its return of investments, which is 23.50%, and its return on assets is 18.50%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.90%. With a sales growth of 11.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 3 and 2.6 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 2.11, and the P/S is 6.04, along with a P/B of 5.95. Meanwhile it has a p/cash of 17.88.